Advances in Drug Discovery Research in Europe
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 1560
Special Issue Editors
Interests: medicinal chemistry; organic chemistry; neurodegenerative diseases; bioactive compounds and drug design; toxicology
Special Issues, Collections and Topics in MDPI journals
Interests: drug discovery; multitarget-directed ligands; neurodegenerative diseases; infectious diseases; biological and toxicological screenings
Special Issues, Collections and Topics in MDPI journals
Interests: drug discovery; nanomedicine; ADME-Tox; neurodegenerative; infectious diseases; antioxidants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Over the last few years, new technological and scientific developments have been revolutionizing the drug discovery process. Phenotypic and target-based medium-to-high-throughput screening of compound libraries are currently the main technologies used to identify new hit compounds. However, they have been recently employed in combination with techniques founded in genomics, molecular and structural biology and molecular modeling, enabling not only the design of better and safer compounds, but also the understanding of fundamental cellular and molecular mechanisms in different disease states.
In the present Special Issue, we invite authors based in Europe to submit research articles enclosing a wide range of topics in the field of drug discovery, including, but not limited to, the design and synthesis of new chemical entities, biological and toxicological screenings with synthetic or natural compounds and development of drug delivery systems. High-quality reviews in the field will also be accepted.
Dr. Sofia Benfeito
Dr. Daniel Chavarria
Prof. Dr. Fernanda Borges
Dr. Fernando Cagide
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics
- anti-inflammatory agents
- cancer
- cardiovascular diseases
- diabetes
- drug delivery
- enzyme inhibition
- infectious diseases
- nanosystems/nanomaterials
- natural compounds
- neurodegenerative diseases
- new chemical entities
- pharmacokinetics/pharmacodynamics
- single-target and multitarget-directed ligands
- structure–activity relationships
- structure–property relationships
- structure–toxicity relationships
